News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,662 Results
Type
Article (54523)
Company Profile (101)
Press Release (672021)
Multimedia
Podcasts (179)
Webinars (30)
Section
Business (227234)
Career Advice (3005)
Deals (34707)
Drug Delivery (159)
Drug Development (80951)
Employer Resources (167)
FDA (17547)
Job Trends (15253)
News (341966)
Policy (34240)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (2798)
Academic (2)
Accelerated approval (60)
ADA (45)
Adcomms (39)
Allergies (205)
Alliances (52162)
ALS (234)
Alzheimer's disease (1927)
Antibody-drug conjugate (ADC) (538)
Approvals (17976)
Artificial intelligence (818)
ASCO (318)
Autoimmune disease (357)
Automation (67)
Bankruptcy (354)
Best Places to Work (11796)
BIO (71)
BIOSECURE Act (22)
Biosimilars (246)
Biotechnology (81)
Bladder cancer (202)
Brain cancer (78)
Breast cancer (817)
Cancer (6489)
Cardiovascular disease (532)
Career advice (2564)
Career pathing (51)
CAR-T (369)
CDC (72)
Celiac Disease (2)
Cell therapy (1037)
Cervical cancer (55)
Clinical research (71004)
Collaboration (2355)
Commercialization (1)
Company closure (8)
Compensation (1254)
Complete response letters (110)
COVID-19 (2811)
CRISPR (119)
C-suite (1299)
Cystic fibrosis (157)
Data (8733)
Decentralized trials (3)
Denatured (62)
Depression (191)
Dermatology (102)
Diabetes (675)
Diagnostics (7158)
Digital health (66)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (406)
Drug pricing (229)
Drug shortages (32)
Duchenne muscular dystrophy (318)
Earnings (83915)
Editorial (77)
Employer branding (21)
Employer resources (154)
Events (105479)
Executive appointments (1176)
FDA (21764)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (21)
Frontotemporal dementia (36)
Funding (1885)
Gene editing (260)
Generative AI (78)
Gene therapy (828)
GLP-1 (1149)
Government (5037)
Grass and pollen (8)
Guidances (424)
Healthcare (19513)
Hematology (187)
HIV (91)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (112)
Immunology and inflammation (310)
Immuno-oncology (112)
Indications (225)
Infectious disease (3198)
Inflammatory bowel disease (232)
Inflation Reduction Act (15)
Influenza (149)
Intellectual property (325)
Interviews (569)
IPO (15924)
IRA (58)
Job creations (3795)
Job search strategy (2073)
JPM (67)
Kidney cancer (22)
Labor market (105)
Layoffs (554)
Leadership (50)
Legal (8064)
Liver cancer (108)
Longevity (31)
Lung cancer (859)
Lymphoma (482)
Machine learning (68)
Management (58)
Manufacturing (1206)
Marketing (7)
MASH (217)
Medical affairs (1)
Medical device (13776)
Medtech (13948)
Mergers & acquisitions (20131)
Metabolic disorders (1695)
mRNA (252)
Multiple sclerosis (211)
NASH (20)
Neurodegenerative disease (502)
Neuropsychiatric disorders (118)
Neuroscience (3638)
Neurotech (1)
NextGen: Class of 2026 (6864)
Non-profit (4940)
Now hiring (38)
Obesity (772)
Opinion (356)
Ovarian cancer (237)
Pain (279)
Pancreatic cancer (358)
Parkinson's disease (412)
Partnered (40)
Patents (663)
Patient recruitment (805)
Peanut (70)
People (58980)
Pharmaceutical (26)
Pharmacy benefit managers (34)
Phase 1 (21971)
Phase 2 (31106)
Phase 3 (23516)
Pipeline (10190)
Policy (381)
Postmarket research (2661)
Preclinical (9315)
Press Release (71)
Prostate cancer (352)
Psychedelics (69)
Radiopharmaceuticals (351)
Rare diseases (1271)
Real estate (6311)
Recruiting (74)
Regulatory (27374)
Reports (47)
Research institute (2583)
Resumes & cover letters (488)
Rett syndrome (47)
RNA editing (27)
RSV (97)
Schizophrenia (189)
Series A (322)
Series B (225)
Service/supplier (11)
Sickle cell disease (130)
Special edition (29)
Spinal muscular atrophy (180)
Sponsored (53)
Startups (3478)
State (2)
Stomach cancer (17)
Supply chain (134)
Tariffs (86)
The Weekly (115)
Vaccines (1241)
Venture capital (123)
Weight loss (504)
Women's health (139)
Worklife (24)
Date
Today (117)
Last 7 days (459)
Last 30 days (1953)
Last 365 days (30360)
2026 (16842)
2025 (30114)
2024 (34281)
2023 (38803)
2022 (49733)
2021 (54060)
2020 (53583)
2019 (47650)
2018 (36246)
2017 (32947)
2016 (32287)
2015 (37175)
2014 (30332)
2013 (26498)
2012 (28036)
2011 (28345)
2010 (27101)
Location
Africa (948)
Alabama (97)
Alaska (6)
Arizona (344)
Arkansas (14)
Asia (43592)
Australia (7142)
California (13222)
Canada (3961)
China (1579)
Colorado (597)
Connecticut (607)
Delaware (421)
Europe (98324)
Florida (2112)
Georgia (444)
Hawaii (4)
Idaho (61)
Illinois (1168)
India (101)
Indiana (633)
Iowa (24)
Japan (603)
Kansas (132)
Kentucky (52)
Louisiana (61)
Maine (91)
Maryland (1638)
Massachusetts (9588)
Michigan (391)
Minnesota (701)
Mississippi (7)
Missouri (158)
Montana (36)
Nebraska (30)
Nevada (149)
New Hampshire (88)
New Jersey (3690)
New Mexico (30)
New York (3636)
North Carolina (1773)
North Dakota (11)
Northern California (6599)
Ohio (435)
Oklahoma (25)
Oregon (42)
Pennsylvania (2649)
Puerto Rico (33)
Rhode Island (49)
South America (1293)
South Carolina (89)
South Dakota (2)
Southern California (5342)
Tennessee (231)
Texas (2278)
United States (48065)
Utah (414)
Vermont (2)
Virginia (349)
Washington D.C. (81)
Washington State (1089)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
726,662 Results for "centers for medicare and medicaid services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OneOncology Approved as a 2026 Qualified Clinical Data Registry by the Centers for Medicare & Medicaid Services
February 25, 2026
·
3 min read
Press Releases
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
December 29, 2025
·
6 min read
Press Releases
Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI™ Effective January 1, 2026
October 28, 2025
·
8 min read
Press Releases
Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
December 4, 2025
·
3 min read
Press Releases
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
November 25, 2025
·
4 min read
Press Releases
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
October 28, 2025
·
7 min read
Press Releases
Ryoncil® Receives J-Code From Medicare & Medicaid Services (CMS) Facilitating Reimbursement and Broader Patient Access
October 3, 2025
·
6 min read
Policy
CGI selected by Centers for Medicare & Medicaid Services to improve Medicare access for more than 65 million beneficiaries nationwide
CGI Federal Inc., a wholly-owned U.S. operating subsidiary of CGI Inc., has been awarded a single award, firm-fixed price contract by the Centers for Medicare & Medicaid Services to help improve access to Medicare for millions of beneficiaries by modernizing the agency’s Health Plan Management System.
March 19, 2024
·
8 min read
Press Releases
Wegovy® is now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge
July 1, 2026
·
13 min read
Policy
The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation
The Centers for Medicare & Medicaid Services revised the National Coverage Determination of allogeneic hematopoietic stem cell transplantation for individuals with myelodysplastic syndromes due to a request for reconsideration prepared by The American Society of Hematology, the American Society for Transplantation and Cellular Therapy®, the National Marrow Donor Program, and the Center for International Blood and Marrow Transplant Research on January 5, 2024.
March 22, 2024
·
2 min read
1 of 72,667
Next
